TrialThe Lancet. Infectious diseases2022

Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial.

Igor Smolenov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.